acid alendronic/colecalciferol mylan 70 mg/5600 ui
ge pharmaceuticals ltd. - bulgaria - acid alendronicum+colecalciferolum - compr. - 70mg/5600ui - med. ce influenteaza in structura osoasa si mineralizare bifosfonati in combinatii
actonel 75 mg
warner chilcott deutschland gmbh - germania - acid risedronicum - compr. film. - 75mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
acid alendronic aurobindo 70 mg
apl swift services (malta) limited - malta - acid alendronicum - compr. - 70mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
actonel saptamanal 35 mg
warner chilcott deutschland gmbh - germania - acid risedronicum - compr. film. - 35mg - med. ce influenteaza in structura osoasa si mineralizarea bifosfonati
risedronat aurobindo 35 mg
apl swift services (malta) limited - malta - acid risedronicum - compr. film. - 35mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
risedronat aurobindo 75 mg
apl swift services (malta) limited - malta - acid risedronicum - compr. film. - 75mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
actonel 35 mg
balkanpharma dupnitsa ad - bulgaria - acid risedronicum - compr. gastrorez. - 35mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agenți antineoplazici - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologice - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
risedronat sodic zentiva 35 mg comprimate filmate
zentiva k.s. - acid risedronicum - comprimate filmate - 35 mg